Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Infectious Diseases|January 1, 1987
In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in EgyptI A Mikhail, A L Bourgeois, K C Hyams, et al.
Frontiers in Immunology|November 17, 2025
TAPBPR promotes editing of the HLA-B44 peptide repertoire, increasing the presentation of peptides containing a C-terminal tryptophanAure Aflalo, Arwen F Altenburg, Marcel Wacker, et al.
Cancers|July 12, 2020
HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell TransplantationMalte Roerden, Annika Nelde, Jonas S Heitmann, et al.
BMJ Open|October 17, 2020
Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinomaJonas S Heitmann, Juliane S Walz, Martin Pflügler, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 16, 2022
Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohortChristian M Tegeler, Tatjana Bilich, Yacine Maringer, et al.
Journal of Cancer Research and Clinical Oncology|August 15, 2019
The role of autologous stem cell transplantation in peripheral T cell lymphoma: a long-term follow-up single-center experienceMalte Roerden, Juliane S Walz, Martin R Müller, et al.
Cancers|May 14, 2022
HLA-DR Presentation of the Tumor Antigen MSLN Associates with Clinical Outcome of Ovarian Cancer PatientsChristian M Tegeler, Jonas Scheid, Hans-Georg Rammensee, et al.
Oncogene|January 29, 2013
Cystathionase mediates senescence evasion in melanocytes and melanoma cellsC Leikam, A Hufnagel, S Walz, et al.
Leukemia & Lymphoma|March 2, 2021
Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcomeMalte Roerden, Melanie Märklin, Helmut R Salih, et al.
Science Immunology|November 1, 2022
Durable spike-specific T cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccinationYacine Maringer, Annika Nelde, Sarah M Schroeder, et al.
Pageof 10